Logo of eidLink to Publisher's site
Emerg Infect Dis. 2001 Jan-Feb; 7(1): 24–34.
PMCID: PMC2631682

Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Abstract

The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and quinolone resistance in Campylobacter and track resistance trends in human clinical isolates in relation to use of these agents in food animals. Susceptibility data suggest that erythromycin and other macrolides should remain the drugs of choice in most regions, with systematic surveillance and control measures maintained, but fluoroquinolones may now be of limited use in the empiric treatment of Campylobacter infections in many regions.

Full Text

The Full Text of this article is available as a PDF (106K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Allos BM, Blaser MJ. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis. 1995 May;20(5):1092–1101. [PubMed]
  • Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996 Jun;22(6):1019–1025. [PubMed]
  • Wiström J, Norrby SR. Fluoroquinolones and bacterial enteritis, when and for whom? J Antimicrob Chemother. 1995 Jul;36(1):23–39. [PubMed]
  • Piddock LJ. Quinolone resistance and Campylobacter spp. J Antimicrob Chemother. 1995 Dec;36(6):891–898. [PubMed]
  • Adler-Mosca H, Lüthy-Hottenstein J, Martinetti Lucchini G, Burnens A, Altwegg M. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):953–957. [PubMed]
  • Endtz HP, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 1991 Feb;27(2):199–208. [PubMed]
  • Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med. 1999 May 20;340(20):1525–1532. [PubMed]
  • Yan W, Taylor DE. Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 1991 Oct;35(10):1989–1996. [PMC free article] [PubMed]
  • Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother. 1997 Dec;41(12):2621–2628. [PMC free article] [PubMed]
  • Wang Y, Huang WM, Taylor DE. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother. 1993 Mar;37(3):457–463. [PMC free article] [PubMed]
  • Ruiz J, Goñi P, Marco F, Gallardo F, Mirelis B, Jimenez De Anta T, Vila J. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol. 1998;42(3):223–226. [PubMed]
  • Gibreel A, Sjögren E, Kaijser B, Wretlind B, Sköld O. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob Agents Chemother. 1998 Dec;42(12):3276–3278. [PMC free article] [PubMed]
  • Gootz TD, Martin BA. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 1991 May;35(5):840–845. [PMC free article] [PubMed]
  • Charvalos E, Tselentis Y, Hamzehpour MM, Köhler T, Pechere JC. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother. 1995 Sep;39(9):2019–2022. [PMC free article] [PubMed]
  • Aarestrup FM, Nielsen EM, Madsen M, Engberg J. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob Agents Chemother. 1997 Oct;41(10):2244–2250. [PMC free article] [PubMed]
  • Cabrita J, Rodrigues J, Bragança F, Morgado C, Pires I, Gonçalves AP. Prevalence, biotypes, plasmid profile and antimicrobial resistance of Campylobacter isolated from wild and domestic animals from northeast Portugal. J Appl Bacteriol. 1992 Oct;73(4):279–285. [PubMed]
  • Sáenz Y, Zarazaga M, Lantero M, Gastanares MJ, Baquero F, Torres C. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother. 2000 Feb;44(2):267–271. [PMC free article] [PubMed]
  • Moore JE, Madden RH, Kerr JR, Wilson TS, Murphy PG. Erythromycin-resistant thermophilic Campylobacter species isolated from pigs. Vet Rec. 1996 Mar 30;138(13):306–307. [PubMed]
  • Nielsen EM, Nielsen NL. Serotypes and typability of Campylobacter jejuni and Campylobacter coli isolated from poultry products. Int J Food Microbiol. 1999 Feb 18;46(3):199–205. [PubMed]
  • Endtz HP, Mouton RP, van der Reyden T, Ruijs GJ, Biever M, van Klingeren B. Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products. Lancet. 1990 Mar 31;335(8692):787–787. [PubMed]
  • Li CC, Chiu CH, Wu JL, Huang YC, Lin TY. Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan. Scand J Infect Dis. 1998;30(1):39–42. [PubMed]
  • Engberg Jørgen, Gerner-Smidt Peter, Scheutz Flemming, Møller Nielsen Eva, On Stephen Louis William, Mølbak Kåre. Water-borne Campylobacter jejuni infection in a Danish town---a 6-week continuous source outbreak. Clin Microbiol Infect. 1998 Jan;4(11):648–656. [PubMed]
  • On SL, Nielsen EM, Engberg J, Madsen M. Validity of SmaI-defined genotypes of Campylobacter jejuni examined by SalI, KpnI, and BamHI polymorphisms: evidence of identical clones infecting humans, poultry, and cattle. Epidemiol Infect. 1998 Jun;120(3):231–237. [PMC free article] [PubMed]
  • Nielsen EM, Engberg J, Madsen M. Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine. FEMS Immunol Med Microbiol. 1997 Sep;19(1):47–56. [PubMed]
  • Gallardo F, Gascón J, Ruiz J, Corachan M, Jimenez de Anta M, Vila J. Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility. J Travel Med. 1998 Mar;5(1):23–26. [PubMed]
  • Mattila L, Peltola H, Siitonen A, Kyrönseppä H, Simula I, Kataja M. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis. 1993 Oct;17(4):779–782. [PubMed]
  • Rautelin H, Renkonen OV, Kosunen TU. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother. 1991 Oct;35(10):2065–2069. [PMC free article] [PubMed]
  • Sjögren E, Kaijser B, Werner M. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother. 1992 Dec;36(12):2847–2849. [PMC free article] [PubMed]
  • Sjögren E, Lindblom GB, Kaijser B. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J Antimicrob Chemother. 1997 Aug;40(2):257–261. [PubMed]
  • Engberg Jørgen, Andersen Sigrid, Skov Robert, Aarestrup Frank Møller, Gerner-Smidt Peter. Comparison of two agar dilution methods and three agar diffusion methods, including the Etest, for antibiotic susceptibility testing of thermophilic Campylobacter species. Clin Microbiol Infect. 1999 Sep;5(9):580–584. [PubMed]
  • Orr KE, Lightfoot NF, Sisson PR, Harkis BA, Tweddle JL, Boyd P, Carroll A, Jackson CJ, Wareing DR, Freeman R. Direct milk excretion of Campylobacter jejuni in a dairy cow causing cases of human enteritis. Epidemiol Infect. 1995 Feb;114(1):15–24. [PMC free article] [PubMed]
  • Pearson AD, Greenwood MH, Donaldson J, Healing TD, Jones DM, Shahamat M, Feltham RK, Colwell RR. Continuous source outbreak of campylobacteriosis traced to chicken. J Food Prot. 2000 Mar;63(3):309–314. [PubMed]
  • Owen RJ, Leeton S. Restriction fragment length polymorphism analysis of the flaA gene of Campylobacter jejuni for subtyping human, animal and poultry isolates. FEMS Microbiol Lett. 1999 Jul 15;176(2):345–350. [PubMed]
  • Funke G, Baumann R, Penner JL, Altwegg M. Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea. Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):612–615. [PubMed]
  • Segreti J, Gootz TD, Goodman LJ, Parkhurst GW, Quinn JP, Martin BA, Trenholme GM. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis. 1992 Apr;165(4):667–670. [PubMed]
  • Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. 1998 Jan;26(1):91–96. [PubMed]
  • Ellis-Pegler RB, Hyman LK, Ingram RJ, McCarthy M. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. J Antimicrob Chemother. 1995 Jul;36(1):259–263. [PubMed]
  • Molina J, Casin I, Hausfater P, Giretti E, Welker Y, Decazes J, Garrait V, Lagrange P, Modaï J. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS. 1995 Aug;9(8):881–885. [PubMed]
  • Chatzipanagiotou S, Papavasiliou E, Malamou-Lada E. Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece. Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):566–568. [PubMed]
  • Reina J, Ros MJ, Serra A. Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother. 1994 Dec;38(12):2917–2920. [PMC free article] [PubMed]
  • Sánchez R, Fernández-Baca V, Díaz MD, Muñoz P, Rodríguez-Créixems M, Bouza E. Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother. 1994 Sep;38(9):1879–1882. [PMC free article] [PubMed]
  • Berghold Christian, Fürpaß Therasia, Marth Egon. Further increase in ciprofloxacin-resistant Campylobacter jejuni/coli in Styria, Austria. Clin Microbiol Infect. 1999 Jan;5(1):59–60. [PubMed]
  • Gaudreau C, Gilbert H. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob Agents Chemother. 1998 Aug;42(8):2106–2108. [PMC free article] [PubMed]
  • Hänninen ML, Pajarre S, Klossner ML, Rautelin H. Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis. J Clin Microbiol. 1998 Jun;36(6):1787–1789. [PMC free article] [PubMed]
  • Varga J, Fodor L. Biochemical characteristics, serogroup distribution, antibiotic susceptibility and age-related significance of Campylobacter strains causing diarrhoea in humans in Hungary. Zentralbl Bakteriol. 1998 Jul;288(1):67–73. [PubMed]
  • Dowling J, MacCulloch D, Morris AJ. Antimicrobial susceptibility of Campylobacter and Yersinia enterocolitica isolates. N Z Med J. 1998 Jul 24;111(1070):281–281. [PubMed]
  • Lim YS, Tay L. A one-year study of enteric Campylobacter infections in Singapore. J Trop Med Hyg. 1992 Apr;95(2):119–123. [PubMed]
  • Navarro F, Miró E, Mirelis B, Prats G. Campylobacter spp antibiotic susceptibility. J Antimicrob Chemother. 1993 Dec;32(6):906–907. [PubMed]
  • Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998 Feb;26(2):341–345. [PubMed]
  • Murphy GS, Jr, Echeverria P, Jackson LR, Arness MK, LeBron C, Pitarangsi C. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. Clin Infect Dis. 1996 May;22(5):868–869. [PubMed]
  • Baker CN. The E-Test and Campylobacter jejuni. Diagn Microbiol Infect Dis. 1992 Jul;15(5):469–472. [PubMed]
  • Hirschl AM, Wolf D, Berger J, Rotter ML. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin. Zentralbl Bakteriol. 1990 Apr;272(4):443–447. [PubMed]
  • Feierl G, Pschaid A, Sixl B, Marth E. Increase of ciprofloxacin resistance in Campylobacter species in Styria, Austria. Zentralbl Bakteriol. 1994 Nov;281(4):471–474. [PubMed]
  • Perez-Trallero E, Urbieta M, Lopategui CL, Zigorraga C, Ayestaran I. Antibiotics in veterinary medicine and public health. Lancet. 1993 Nov 27;342(8883):1371–1372. [PubMed]
  • Reina J. Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter spp. Lancet. 1992 Oct 24;340(8826):1035–1036. [PubMed]
  • Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, Olafson RP, Echeverria P, Sadoff JC, Taylor DN. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis. 1995 Sep;21(3):536–541. [PubMed]
  • Bowler IC, Connor M, Lessing MP, Day D. Quinolone resistance and Campylobacter species. J Antimicrob Chemother. 1996 Aug;38(2):315–315. [PubMed]
  • Sam WI, Lyons MM, Waghorn DJ. Increasing rates of ciprofloxacin resistant campylobacter. J Clin Pathol. 1999 Sep;52(9):709–709. [PMC free article] [PubMed]
  • Shah PM, Schäfer V, Knothe H. Medical and veterinary use of antimicrobial agents: implications for public health. A clinician's view on antimicrobial resistance. Vet Microbiol. 1993 Jun;35(3-4):269–274. [PubMed]
  • Reina J, Borrell N, Serra A. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991. Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1163–1166. [PubMed]
  • Tee W, Mijch A, Wright E, Yung A. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. Clin Infect Dis. 1995 Sep;21(3):634–638. [PubMed]
  • Threlfall E John, Ward Linda R, Rowe Bernard. Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales-the current situation. Clin Microbiol Infect. 1999 Mar;5(3):130–134. [PubMed]
  • Mølbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, Gerner-Smidt P, Petersen AM, Wegener HC. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med. 1999 Nov 4;341(19):1420–1425. [PubMed]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...